Recursion
Recursion (Recursion Pharmaceuticals, NASDAQ RXRX) is a clinical-stage TechBio company that industrializes drug discovery by combining wet-lab automation, proprietary biological and chemical datasets (over 50 petabytes), and machine learning in its Recursion Operating System. Its Valence Labs unit runs machine-learning research, and the company has published open datasets (RxRx) for the ML community. Recursion was surfaced as a portfolio company of DCVC, Obvious Ventures, and the SoftBank Vision Fund. As of this enrichment pass the company exposes no public developer API, developer portal, or machine-readable API artifacts; this profile records its identity and a live domain-security probe.
Recursion is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Drug Discovery, and Artificial Intelligence.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API